Vincent Brichard is a Venture Partner with in the EQT Life Sciences team. Vincent work for LSP from 2016 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Previously, Vincent was Senior Vice-President and member of the Executive Committee at GSK Biologicals.
Vincent holds a M.D., is specialized in oncology, has a Ph.D. from the Ludwig Institute for Cancer Research, has been a researcher with the FNRS/NFWO and holds an exec MBA from the Harvard Business School. Based on his experience, translated by more than 90 primary research publications and reviews, he supports companies, organizations, institutions, and individuals in the fields of immuno-oncology, auto-immunity and vaccines.